Back to search

Article

Engineered extracellular vesicles targeting BACE1 reduces amyloid-beta plaque formation in a genetic mouse model of Alzheimer’s Disease

2026-08-11

Abstract excerpt

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by the accumulation of amyloid-β (Aβ) plaques, neurodegeneration, and cognitive decline. β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) catalyzes the rate-limiting step in Aβ production and remains a therapeutic target for AD. However, effective delivery of RNA therapeutics to the brain remains challenging due to the blo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b2ce5835-306b-5922-9212-ebddb83a5720
DOI
10.64898/2026.08.10.744066
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Engineered extracellular vesicles targeting BACE1 reduces amyloid-beta plaque formation in a genetic mouse model of Alzheimer’s DiseaseDOI 10.64898/2026.08.10.744066
Select a neighboring publication to make it the new centre.